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Introduction
examination was otherwise unremarkable. Laboratory results included sedimentation rate 118 mm/h, haemoLithium salts are a commonly used and quite effective globin 153 g/l, haematocrit 0.45, leukocytes 8.9 g/l, therapy for unipolar and bipolar affective disorders. thrombocytes 285 g/l, total protein 51 g/l, serum The more commonly reported renal side-effects during albumin 22 g/l, blood urea 4.7 mmol/l, serum creatinlong term lithium therapy are nephrogenic diabetes ine 75 mmol/l, sodium 141 mmol/l, serum potassium insipidus, chronic interstitial nephropathy, and renal 4.7 mmol/l, total cholesterol 11.4 mmol/l, serum tubular acidosis [1] . lithium 0.43 mmol/l (normal range 0.3-1 mmol/l ). The The nephrotic syndrome is a rare but recognized 24-h urine collection contained 16 g of proteins (82% complication of lithium therapy which was described albumin) without Bence Jones proteins. Creatinine the first time in 1973 by Duflot et al. [2] . A comprehens-clearance was 65 ml/min. Urinalysis showed 3-5 erythive search of the world literature shows that 19 cases rocytes and 3-5 leukocytes. Urinary concentration of have been reported to date [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] . These cases have sodium was 5 mmol/l and of potassium 28 mmol/l. been associated with different glomerular lesions such Serology for HBV, HCV, and HIV was negative. as minimal-change disease, membranous nephropathy, Rheumatoid factor, ASLO, antinuclear and anti-DNA or focal glomerulosclerosis. In general this complica-antibodies were also negative. Ultrasonogaphic examtion is observed during the first year of lithium therapy ination showed moderately enlarged kidneys and a but we report the case of a woman who developed a percutaneous renal biopsy was performed. nephrotic syndrome after 20 years of lithium therapy Light-microscopy examination of the biopsy and in which the nephrotic syndrome rapidly and revealed glomeruli without any significant morpholocompletely disappeared after withdrawal of lithium gical abnormality. There were two small foci of tubular atrophy and interstitial inflammation. Electronwithout need of steroid therapy.
microscopy showed diffuse epithelial cell foot process fusion without any electron-dense deposit. The histo-
Case report
logical findings fulfilled the diagnosis of minimalchange disease. Direct immunofluorescence showed A 40-year-old white Caucasian female was referred to slight finely granular deposits of IgG and IgM in the glomeruli, with predominant mesangial localization. our hospital because of a nephrotic syndrome. She had There were no deposits of IgA, C3c and fibrin/ been on lithium therapy for 20 years because of an fibrinogen. affective disorder. Her lithium levels had always been
The diagnosis of minimal-change disease secondary within the therapeutic range, with normal creatinine to lithium carbonate therapy was considered and the levels and without proteinuria. A few days before drug was discontinued. Within 6 weeks after cessation admission, she consulted her practitioner because of of the drug we observed a complete remission of the generalized oedema. A nephrotic syndrome was dianephrotic syndrome (proteinuria<100 mg/day). gnosed and the patient was referred to our hospital for further investigations. On admission, her medication consisted of imipramine ( TofranilA) Nephrotic syndrome during lithium therapy 2729 syndrome is very rare. We carried out a comprehensive up of 1 to 144 months). As indicated above, in four patients lithium had to be reintroduced due to search of the world literature with MEDLINE on the last 25 years with an analysis of cross-references. We worsening of psychiatric symptoms [5] [6] [7] 13] . The nephrotic syndrome recurred in all patients within a found nineteen reported cases [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] . Strictly speaking the demonstration of a relationship between a drug few weeks following the reintroduction. In two of them an alternative psychiatric treatment could be givenand a clinical adverse event include (1) the appearance of the side-effect during the therapy, (2) its regression with a new remission of the nephrotic syndrome [6, 13] .
In the two remaining patients this was not possible after drug discontinuation, and (3) the reappearance of the same adverse event after a new challenge. It and long-term steroid therapy was given-with clinical improvement but persistence of a significant proshould be noted that these strict diagnostic criteria (including a new challenge with the drug followed by teinuria [5, 7] . These observations emphasize the high risk of recurrence in patients having already developed recurrence of the nephrotic syndrome) were fulfilled in only four of the cases reported in the literature. a nephrotic syndrome under lithium therapy.
The three last cases reported in Table 1 (cases no Noteworthy in all these four cases the reintroduction of lithium therapy was indicated for therapeutic 18-20) had a quite different clinical course [15, 16 ] . All developed chronic renal failure. These cases were reasons (i.e. psychiatric symptoms) and not for diagnostic purposes [5] [6] [7] 13] . In most cases the rapid remarkable for a quite different clinical presentation as well as for the glomerular lesions-with diffuse or remission of the nephrotic syndrome after lithium discontinuation was considered to be sufficient to sup-focal glomerulosclerosis which were accompanied in two cases by severe interstitial fibrosis. These three port the link between lithium therapy and nephrotic syndrome-as we did in our case.
cases were also particular by the fact that lithium therapy was pursued for a long period despite signs of We summarized some clinical and biological data concerning the reported cases in Table 1 . This table renal involvement well before the development of the nephrotic syndrome. Case 18 already had a marked shows that both genders were equally represented and that the age of the reported cases varied from 14 to 78 chronic renal insufficiency (creatinine 370 mmol/l ) 3 years before the development of the nephrotic synyears. At the time of diagnosis the 24-h proteinuria varied from 3 to 69 g/day and in all but five cases the drome but lithium therapy had nevertheless been continued. Case 19 already had a chronic renal lithium levels were within the therapeutic range. In the majority of these cases (12/19, 63%) the nephrotic insufficiency when the nephrotic syndrome developed.
In these two cases the renal insufficiency was probably syndrome became apparent during the first year after the introduction of lithium therapy, but in a few it related to the presence of severe interstitial lesions.
The nephrotic syndrome partially regressed after discodeveloped after more than 10 years of treatment. Our patient was managed with lithium for 20 years before ntinuation of lithium, while the renal function only slightly improved. Case 20 had a significant proteinuria the nephrotic syndrome developed and this is the longest period reported to date.
(dipstick 3+) 3 years before the nephrotic syndrome developed and the renal biopsy was performed. After Table 1 shows that among the 20 cases reported, 17 (nos 1-17) had a similar and quite typical clinical the biopsy the lithium therapy was not discontinued (a converting enzyme inhibitor was prescribed ) and course with the onset of a nephrotic syndrome while under lithium therapy and a rapid remission of the over the following 10 months the patient developed progressive renal failure, worsening nephrotic synnephrotic syndrome after discontinuation of the druggenerally within 2-6 weeks. Four of these patients were drome, and inferior vena cava occlusion, and died of pulmonary embolus [16 ] . In these three cases the treated with steroids to hasten the recovery, but for the majority steroids were not necessary to achieve relationship between lithium therapy and the glomerular lesions is less evident. The glomerulosclerosis may complete remission. The case reported by Singer et al. (no. 17 ) is particularly interesting. In this patient the also have been secondary to the interstitial damage, possibly associated to long-standing treatment with lithium therapy could not be discontinued because of severe psychiatric symptoms but a complete remission lithium. Therefore whether glomerulosclerosis reflects a longer duration of the disease, a distinct primary was achieved with a course of 4 months of low-dose azathioprine (0.6 mg/kg/day) without any recurrence lesion or a secondary lesion remains unclear for these cases. of nephrotic syndrome during a 12-year follow-up [14, 17] . A renal biopsy was performed in 15 of these Little is known about the mechanism by which lithium can cause the nephrotic syndrome and minimal-17 cases. In 13 cases the pathological diagnosis was minimal-change disease, while the two others had change disease. Some authors theorized that lithium could interact with anionic sites of the glomerular membranous nephropathy [13, 14] . Eight of these 17 cases also had acute renal failure (ARF ) along with capillaries known to limit the passage of macromolecules and thus cause proteinuria [3, 6 ] . This would the nephrotic syndrome. In two of them the ARF was related to acute tubular necrosis, in five the ARF was not explain why other cations similar to lithium do not cause similar problems. There is evidence that prerenal, and in the last case the ARF was probably related to concomitant acute lithium intoxication [2] . minimal-change disease is associated with abnormal lymphocyte function. Since lithium has been demonIn all these patients the renal function recovered and none of them developed chronic renal failure (follow-strated to modulate lymphokines production by T-cells, Yes°N ote: one of the three cases reported by Santella et al. [16 ] is not included as the patient had stopped taking lithium 5 years before the NS developed. MCD, minimal-change disease; MN, membranous nephropathy; IF, interstitial fibrosis; DGS, diffuse glomerulosclerosis; FSG, focal segmental glomerulosclerosis; ATN, acute tubular necrosis; ARF, acute renal failure; PS, present study. *Cases in which the lithium therapy had to be reintroduced and in which the nephrotic syndrome recurred. **Recurrence treated with steroids. AZA, remission after 4 months of low-dose azathioprine (0.6 mg/kg/day) while lithium continued; no recurrence after 12 years [17] .
